Pages that link to "Q37696308"

The following pages link to Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors (Q37696308):

Displaying 9 items.

• Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives (Q33729711) (← links)
• Mutational profile of primary breast diffuse large B-cell lymphoma (Q47118882) (← links)
• Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets. (Q48248047) (← links)
• Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells. (Q52643503) (← links)
• Evaluation of latent membrane protein 1 and microRNA-155 for the prognostic prediction of diffuse large B cell lymphoma. (Q54962558) (← links)
• TP53 and OSBPL10 alterations in diffuse large B-cell lymphoma: prognostic markers identified via exome analysis of cases with extreme prognosis. (Q55177617) (← links)
• Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy (Q90101887) (← links)
• Genetic alterations and their clinical implications in DLBCL (Q92283033) (← links)
• CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential (Q92971214) (← links)